Sustained regression of tumors upon MYC inactivation requires p53 or thrombospondin-1 to reverse the angiogenic switch

Sylvie Giuriato, Sandra Ryeom, Alice C. Fan, Pavan Bachireddy, Ryan C. Lynch, Matthew J. Rioth, Jan Van Riggelen, Andrew M. Kopelman, Emmanuelle Passegué, Flora Tang, Judah Folkman, Dean W. Felsher

Research output: Contribution to journalArticlepeer-review

124 Scopus citations

Fingerprint

Dive into the research topics of 'Sustained regression of tumors upon MYC inactivation requires p53 or thrombospondin-1 to reverse the angiogenic switch'. Together they form a unique fingerprint.

Medicine & Life Sciences